Quinupristin/dalfopristin: a review of its use in the management of serious gram-positive infections

HM Lamb, DP Figgitt, D Faulds - Drugs, 1999 - Springer
Quimipristin/dalfopristin is the first parenteral streptogramin antibacterial agent, and is a 30:
70 (w/w) ratio of 2 semisynthetic pristinamycin derivatives. The combination has inhibitory …

Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients

D Simpson, K Wellington - Drugs, 2004 - Springer
Summary Abstract Nicorandil (Adancor®, Angicor®, Dancor®, Nikoril®[Europe],
Ikorel®[Europe and Oceania], Sigmart®[Japan, Korea and Taiwan]) is an adenosine …

Lipid nanoparticles as carriers for delivery of anti-inflammatory drugs

AB Kovačević, SMC Silva, S Doktorovová - Emerging Nanotechnologies in …, 2018 - Elsevier
Anti-inflammatory drugs are used in therapy of acute and chronic diseases with inflammatory
etiology. Therapeutic delivery of anti-inflammatory drugs to the desired site of action and at …

[HTML][HTML] Bariatric surgery and the effects on drug pharmacokinetics

C Huang, F Master - Gastroenterology, 2016 - pharmaceutical-journal.com
Gastric bypass surgery on obese patient Obesity is a complex chronic multi system condition
and is described as abnormal, excessive fat accumulation. Efforts to educate and promote …